25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Zim Laboratories Limited
Buy, Hold or Sell?

Let's analyze Zim Laboratories Limited together

I guess you are interested in Zim Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zim Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Zim Laboratories Limited

I send you an email if I find something interesting about Zim Laboratories Limited.

1. Quick Overview

1.1. Quick analysis of Zim Laboratories Limited (30 sec.)










1.2. What can you expect buying and holding a share of Zim Laboratories Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR49.00
Expected worth in 1 year
INR80.52
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR31.56
Return On Investment
30.6%

For what price can you sell your share?

Current Price per Share
INR103.06
Expected price per share
INR92.40 - INR128.75
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Zim Laboratories Limited (5 min.)




Live pricePrice per Share (EOD)
INR103.06
Intrinsic Value Per Share
INR-61.21 - INR6.25
Total Value Per Share
INR-12.22 - INR55.24

2.2. Growth of Zim Laboratories Limited (5 min.)




Is Zim Laboratories Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$28.1m$23.6m$4.5m16.1%

How much money is Zim Laboratories Limited making?

Current yearPrevious yearGrowGrow %
Making money$2m$2.8m-$848.1k-41.7%
Net Profit Margin4.7%6.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Zim Laboratories Limited (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Zim Laboratories Limited?

Welcome investor! Zim Laboratories Limited's management wants to use your money to grow the business. In return you get a share of Zim Laboratories Limited.

First you should know what it really means to hold a share of Zim Laboratories Limited. And how you can make/lose money.

Speculation

The Price per Share of Zim Laboratories Limited is INR103.06. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zim Laboratories Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zim Laboratories Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR49.00. Based on the TTM, the Book Value Change Per Share is INR7.88 per quarter. Based on the YOY, the Book Value Change Per Share is INR5.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zim Laboratories Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.040.0%0.040.0%0.060.1%0.030.0%0.030.0%
Usd Book Value Change Per Share0.090.1%0.090.1%0.060.1%0.040.0%0.030.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.090.1%0.090.1%0.060.1%0.040.0%0.030.0%
Usd Price Per Share1.12-1.12-0.85-0.39-0.20-
Price to Earnings Ratio26.83-26.83-14.41-8.25-4.12-
Price-to-Total Gains Ratio12.03-12.03-14.26-13.14-13.14-
Price to Book Ratio1.94-1.94-1.76-0.74-0.37-
Price-to-Total Gains Ratio12.03-12.03-14.26-13.14-13.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.216108
Number of shares822
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.090.04
Usd Total Gains Per Share0.090.04
Gains per Quarter (822 shares)76.5435.30
Gains per Year (822 shares)306.16141.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103062962140131
216126023279272
319179085419413
42122312147558554
52152915208698695
621835182610837836
732140213212977977
83244624381311161118
94275227441512561259
104305830501713951400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.01.00.091.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.01.00.091.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.01.00.091.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Zim Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--7.8817.8810%5.056+56%3.597+119%2.519+213%
Book Value Per Share--48.99848.9980%41.117+19%38.147+28%31.351+56%
Current Ratio--1.4281.4280%1.724-17%1.445-1%1.358+5%
Debt To Asset Ratio--0.4660.4660%0.413+13%0.479-3%0.528-12%
Debt To Equity Ratio--0.8720.8720%0.705+24%0.931-6%1.163-25%
Dividend Per Share--0.0100.0100%0.012-16%0.043-76%0.084-88%
Eps--3.5393.5390%5.015-29%2.744+29%2.120+67%
Free Cash Flow Per Share---13.362-13.3620%0.175-7746%-0.062-100%0.897-1589%
Free Cash Flow To Equity Per Share--0.3980.3980%0.287+39%0.190+110%-0.288+172%
Gross Profit Margin---0.419-0.4190%-0.143-66%-2.213+428%-1.528+264%
Intrinsic Value_10Y_max--6.246--------
Intrinsic Value_10Y_min---61.215--------
Intrinsic Value_1Y_max--0.841--------
Intrinsic Value_1Y_min---3.127--------
Intrinsic Value_3Y_max--2.362--------
Intrinsic Value_3Y_min---12.056--------
Intrinsic Value_5Y_max--3.686--------
Intrinsic Value_5Y_min---23.832--------
Market Cap5021680948.000+8%4626514710.0004626514710.0000%3520440061.500+31%1629390954.300+184%814695477.150+468%
Net Profit Margin--0.0470.0470%0.061-23%0.038+23%0.033+44%
Operating Margin--0.0690.0690%0.103-33%0.078-11%0.087-21%
Operating Ratio--0.9310.9310%0.913+2%0.929+0%0.920+1%
Pb Ratio2.103+8%1.9381.9380%1.757+10%0.739+162%0.370+424%
Pe Ratio29.117+8%26.82626.8260%14.408+86%8.247+225%4.123+551%
Price Per Share103.060+8%94.95094.9500%72.250+31%33.440+184%16.720+468%
Price To Free Cash Flow Ratio-7.713-9%-7.106-7.1060%413.391-102%81.257-109%40.629-117%
Price To Total Gains Ratio13.060+8%12.03312.0330%14.256-16%13.144-8%13.144-8%
Quick Ratio--0.7010.7010%0.971-28%0.721-3%0.785-11%
Return On Assets--0.0390.0390%0.072-46%0.037+4%0.031+26%
Return On Equity--0.0720.0720%0.122-41%0.069+5%0.056+28%
Total Gains Per Share--7.8917.8910%5.068+56%3.640+117%2.602+203%
Usd Book Value--28172039.80028172039.8000%23640828.000+19%21933193.360+28%18025760.240+56%
Usd Book Value Change Per Share--0.0930.0930%0.060+56%0.042+119%0.030+213%
Usd Book Value Per Share--0.5780.5780%0.485+19%0.450+28%0.370+56%
Usd Dividend Per Share--0.0000.0000%0.000-16%0.001-76%0.001-88%
Usd Eps--0.0420.0420%0.059-29%0.032+29%0.025+67%
Usd Free Cash Flow---7682897.400-7682897.4000%100488.800-7746%-35758.720-100%515893.640-1589%
Usd Free Cash Flow Per Share---0.158-0.1580%0.002-7746%-0.001-100%0.011-1589%
Usd Free Cash Flow To Equity Per Share--0.0050.0050%0.003+39%0.002+110%-0.003+172%
Usd Market Cap59255835.186+8%54592873.57854592873.5780%41541192.726+31%19226813.261+184%9613406.630+468%
Usd Price Per Share1.216+8%1.1201.1200%0.853+31%0.395+184%0.197+468%
Usd Profit--2035075.2002035075.2000%2883271.000-29%1577551.440+29%1219001.360+67%
Usd Revenue--43356079.20043356079.2000%47026197.800-8%38878198.680+12%35340175.180+23%
Usd Total Gains Per Share--0.0930.0930%0.060+56%0.043+117%0.031+203%
 EOD+5 -3MRQTTM+0 -0YOY+13 -235Y+23 -1310Y+24 -12

3.3 Fundamental Score

Let's check the fundamental score of Zim Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1529.117
Price to Book Ratio (EOD)Between0-12.103
Net Profit Margin (MRQ)Greater than00.047
Operating Margin (MRQ)Greater than00.069
Quick Ratio (MRQ)Greater than10.701
Current Ratio (MRQ)Greater than11.428
Debt to Asset Ratio (MRQ)Less than10.466
Debt to Equity Ratio (MRQ)Less than10.872
Return on Equity (MRQ)Greater than0.150.072
Return on Assets (MRQ)Greater than0.050.039
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Zim Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.347
Ma 20Greater thanMa 50106.472
Ma 50Greater thanMa 100108.761
Ma 100Greater thanMa 200110.495
OpenGreater thanClose104.550
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Zim Laboratories Limited

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.

Fundamental data was last updated by Penke on 2024-11-03 04:48:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Zim Laboratories Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Zim Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.7% means that ₹0.05 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zim Laboratories Limited:

  • The MRQ is 4.7%. The company is making a profit. +1
  • The TTM is 4.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.7%TTM4.7%0.0%
TTM4.7%YOY6.1%-1.4%
TTM4.7%5Y3.8%+0.9%
5Y3.8%10Y3.3%+0.5%
4.3.1.2. Return on Assets

Shows how efficient Zim Laboratories Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zim Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.9% Return on Assets means that Zim Laboratories Limited generated ₹0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zim Laboratories Limited:

  • The MRQ is 3.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.9%TTM3.9%0.0%
TTM3.9%YOY7.2%-3.3%
TTM3.9%5Y3.7%+0.2%
5Y3.7%10Y3.1%+0.6%
4.3.1.3. Return on Equity

Shows how efficient Zim Laboratories Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zim Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.2% Return on Equity means Zim Laboratories Limited generated ₹0.07 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zim Laboratories Limited:

  • The MRQ is 7.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.2%TTM7.2%0.0%
TTM7.2%YOY12.2%-5.0%
TTM7.2%5Y6.9%+0.3%
5Y6.9%10Y5.6%+1.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Zim Laboratories Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Zim Laboratories Limited is operating .

  • Measures how much profit Zim Laboratories Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zim Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 6.9% means the company generated ₹0.07  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zim Laboratories Limited:

  • The MRQ is 6.9%. The company is operating less efficient.
  • The TTM is 6.9%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.9%TTM6.9%0.0%
TTM6.9%YOY10.3%-3.4%
TTM6.9%5Y7.8%-0.9%
5Y7.8%10Y8.7%-0.9%
4.3.2.2. Operating Ratio

Measures how efficient Zim Laboratories Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are ₹0.93 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Zim Laboratories Limited:

  • The MRQ is 0.931. The company is less efficient in keeping operating costs low.
  • The TTM is 0.931. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.931TTM0.9310.000
TTM0.931YOY0.913+0.018
TTM0.9315Y0.929+0.002
5Y0.92910Y0.920+0.009
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Zim Laboratories Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Zim Laboratories Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.43 means the company has ₹1.43 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Zim Laboratories Limited:

  • The MRQ is 1.428. The company is just able to pay all its short-term debts.
  • The TTM is 1.428. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.428TTM1.4280.000
TTM1.428YOY1.724-0.296
TTM1.4285Y1.445-0.017
5Y1.44510Y1.358+0.086
4.4.3.2. Quick Ratio

Measures if Zim Laboratories Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zim Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.70 means the company can pay off ₹0.70 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zim Laboratories Limited:

  • The MRQ is 0.701. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.701. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.701TTM0.7010.000
TTM0.701YOY0.971-0.269
TTM0.7015Y0.721-0.020
5Y0.72110Y0.785-0.064
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Zim Laboratories Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Zim Laboratories Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zim Laboratories Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.47 means that Zim Laboratories Limited assets are financed with 46.6% credit (debt) and the remaining percentage (100% - 46.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zim Laboratories Limited:

  • The MRQ is 0.466. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.466. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.466TTM0.4660.000
TTM0.466YOY0.413+0.052
TTM0.4665Y0.479-0.014
5Y0.47910Y0.528-0.049
4.5.4.2. Debt to Equity Ratio

Measures if Zim Laboratories Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zim Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 87.2% means that company has ₹0.87 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zim Laboratories Limited:

  • The MRQ is 0.872. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.872. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.872TTM0.8720.000
TTM0.872YOY0.705+0.167
TTM0.8725Y0.931-0.060
5Y0.93110Y1.163-0.232
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Zim Laboratories Limited generates.

  • Above 15 is considered overpriced but always compare Zim Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 26.83 means the investor is paying ₹26.83 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zim Laboratories Limited:

  • The EOD is 29.117. Based on the earnings, the company is overpriced. -1
  • The MRQ is 26.826. Based on the earnings, the company is overpriced. -1
  • The TTM is 26.826. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD29.117MRQ26.826+2.291
MRQ26.826TTM26.8260.000
TTM26.826YOY14.408+12.418
TTM26.8265Y8.247+18.579
5Y8.24710Y4.123+4.123
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zim Laboratories Limited:

  • The EOD is -7.713. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.106. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.106. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.713MRQ-7.106-0.607
MRQ-7.106TTM-7.1060.000
TTM-7.106YOY413.391-420.497
TTM-7.1065Y81.257-88.363
5Y81.25710Y40.629+40.629
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Zim Laboratories Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.94 means the investor is paying ₹1.94 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Zim Laboratories Limited:

  • The EOD is 2.103. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.938. Based on the equity, the company is underpriced. +1
  • The TTM is 1.938. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.103MRQ1.938+0.166
MRQ1.938TTM1.9380.000
TTM1.938YOY1.757+0.181
TTM1.9385Y0.739+1.199
5Y0.73910Y0.370+0.370
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-03-312021-03-312022-03-312023-03-312024-03-31
Other Stockholders Equity  406,3093,578409,8870409,887-329,58980,298-1,654,613-1,574,315



6.2. Latest Balance Sheet

Balance Sheet of 2024-03-31. All numbers in thousands.

Summary
Total Assets4,468,223
Total Liabilities2,080,762
Total Stockholder Equity2,387,458
 As reported
Total Liabilities 2,080,762
Total Stockholder Equity+ 2,387,458
Total Assets = 4,468,223

Assets

Total Assets4,468,223
Total Current Assets2,276,485
Long-term Assets2,191,738
Total Current Assets
Cash And Cash Equivalents 104,640
Short-term Investments 11,823
Net Receivables 1,001,654
Inventory 812,629
Other Current Assets 357,562
Total Current Assets  (as reported)2,276,485
Total Current Assets  (calculated)2,288,308
+/- 11,823
Long-term Assets
Property Plant Equipment 1,804,495
Goodwill 1,694
Intangible Assets 224,902
Long-term Assets Other 152,277
Long-term Assets  (as reported)2,191,738
Long-term Assets  (calculated)2,183,368
+/- 8,370

Liabilities & Shareholders' Equity

Total Current Liabilities1,594,252
Long-term Liabilities486,510
Total Stockholder Equity2,387,458
Total Current Liabilities
Short-term Debt 732,238
Accounts payable 623,809
Other Current Liabilities 143,700
Total Current Liabilities  (as reported)1,594,252
Total Current Liabilities  (calculated)1,499,747
+/- 94,505
Long-term Liabilities
Long-term Liabilities  (as reported)486,510
Long-term Liabilities  (calculated)0
+/- 486,510
Total Stockholder Equity
Common Stock487,258
Retained Earnings 1,574,315
Accumulated Other Comprehensive Income 1,900,200
Other Stockholders Equity -1,574,315
Total Stockholder Equity (as reported)2,387,458
Total Stockholder Equity (calculated)2,387,458
+/-0
Other
Cash and Short Term Investments 104,640
Common Stock Shares Outstanding 48,719
Current Deferred Revenue94,505
Liabilities and Stockholders Equity 4,468,223
Net Debt 983,604
Net Working Capital 682,233
Short Long Term Debt Total 1,088,244



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-31
> Total Assets 
2,183,141
2,635,867
2,651,187
2,561,565
2,594,029
2,982,907
3,284,503
3,253,024
3,247,822
3,416,284
3,415,786
4,468,223
4,468,2233,415,7863,416,2843,247,8223,253,0243,284,5032,982,9072,594,0292,561,5652,651,1872,635,8672,183,141
   > Total Current Assets 
1,483,835
1,739,037
1,684,082
1,541,357
1,546,302
1,742,391
1,940,913
1,820,305
1,917,602
2,121,366
1,909,480
2,276,485
2,276,4851,909,4802,121,3661,917,6021,820,3051,940,9131,742,3911,546,3021,541,3571,684,0821,739,0371,483,835
       Cash And Cash Equivalents 
239,309
183,923
9,336
7,443
4,241
14,688
4,991
14,610
13,925
34,203
64,205
104,640
104,64064,20534,20313,92514,6104,99114,6884,2417,4439,336183,923239,309
       Short-term Investments 
0
0
0
-4,564
-74,395
-37,341
-61,182
17,093
167,652
12,945
11,950
11,823
11,82311,95012,945167,65217,093-61,182-37,341-74,395-4,564000
       Net Receivables 
773,525
978,509
1,213,360
1,156,531
1,186,494
1,006,967
1,155,581
726,837
816,548
977,467
987,115
1,001,654
1,001,654987,115977,467816,548726,8371,155,5811,006,9671,186,4941,156,5311,213,360978,509773,525
       Inventory 
236,210
311,391
460,990
377,189
354,652
515,608
550,527
563,891
543,472
752,842
537,062
812,629
812,629537,062752,842543,472563,891550,527515,608354,652377,189460,990311,391236,210
       Other Current Assets 
234,791
265,214
396
194
915
205,128
229,814
514,967
469,220
3,855
343,323
357,562
357,562343,3233,855469,220514,967229,814205,128915194396265,214234,791
   > Long-term Assets 
699,306
896,830
967,105
1,020,208
1,047,727
1,240,516
1,343,590
1,432,719
1,330,220
1,294,918
1,506,306
2,191,738
2,191,7381,506,3061,294,9181,330,2201,432,7191,343,5901,240,5161,047,7271,020,208967,105896,830699,306
       Property Plant Equipment 
667,819
830,063
907,430
935,820
900,548
1,111,318
1,133,179
1,175,768
1,100,361
1,129,589
1,215,592
1,804,495
1,804,4951,215,5921,129,5891,100,3611,175,7681,133,1791,111,318900,548935,820907,430830,063667,819
       Goodwill 
0
0
0
0
0
0
1,694
1,694
1,694
1,694
1,694
1,694
1,6941,6941,6941,6941,6941,694000000
       Intangible Assets 
0
14,761
19,897
15,431
23,723
47,428
121,329
132,049
117,960
103,494
139,206
224,902
224,902139,206103,494117,960132,049121,32947,42823,72315,43119,89714,7610
       Other Assets 
30,977
51,496
0
0
0
0
0
0
0
0
0
0
000000000051,49630,977
> Total Liabilities 
1,114,988
1,475,604
1,709,083
1,578,191
1,414,378
1,616,878
1,773,319
1,714,814
1,640,322
1,659,189
1,412,326
2,080,762
2,080,7621,412,3261,659,1891,640,3221,714,8141,773,3191,616,8781,414,3781,578,1911,709,0831,475,6041,114,988
   > Total Current Liabilities 
891,985
1,028,947
1,333,205
1,230,680
1,135,508
1,414,042
1,551,718
1,434,350
1,420,355
1,459,099
1,107,871
1,594,252
1,594,2521,107,8711,459,0991,420,3551,434,3501,551,7181,414,0421,135,5081,230,6801,333,2051,028,947891,985
       Short-term Debt 
416,893
439,677
554,131
612,182
530,382
608,624
550,442
639,005
603,230
336,679
365,158
732,238
732,238365,158336,679603,230639,005550,442608,624530,382612,182554,131439,677416,893
       Accounts payable 
239,670
349,701
641,153
469,651
450,490
662,641
719,525
660,011
648,710
810,709
582,390
623,809
623,809582,390810,709648,710660,011719,525662,641450,490469,651641,153349,701239,670
       Other Current Liabilities 
235,422
239,569
6,504
17,675
5,741
89
2,434
452
188
430
70,512
143,700
143,70070,5124301884522,434895,74117,6756,504239,569235,422
   > Long-term Liabilities 
223,003
446,657
375,878
347,511
278,870
202,836
221,601
280,464
219,967
200,090
304,455
486,510
486,510304,455200,090219,967280,464221,601202,836278,870347,511375,878446,657223,003
> Total Stockholder Equity
1,068,153
1,160,263
942,104
983,374
1,179,651
1,366,029
1,511,184
1,538,210
1,607,500
1,757,095
2,003,460
2,387,458
2,387,4582,003,4601,757,0951,607,5001,538,2101,511,1841,366,0291,179,651983,374942,1041,160,2631,068,153
   Common Stock
79,985
79,985
79,985
79,985
80,291
80,597
161,195
161,807
162,419
162,419
487,258
487,258
487,258487,258162,419162,419161,807161,19580,59780,29179,98579,98579,98579,985
   Retained Earnings 
508,052
600,162
371,303
412,664
597,848
785,740
925,237
950,656
1,019,981
1,165,941
1,405,670
1,574,315
1,574,3151,405,6701,165,9411,019,981950,656925,237785,740597,848412,664371,303600,162508,052
   Accumulated Other Comprehensive Income 
4,000
4,000
4,000
14,609
21,756
16,363
22,021
19,438
15,213
18,848
30,234
1,900,200
1,900,20030,23418,84815,21319,43822,02116,36321,75614,6094,0004,0004,000
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
476,116
476,116
486,816
476,116
479,756
483,329
402,731
406,309
409,887
409,887
80,298
-1,574,315
-1,574,31580,298409,887409,887406,309402,731483,329479,756476,116486,816476,116476,116



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-03-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,674,244
Cost of Revenue-2,407,357
Gross Profit1,266,8871,266,887
 
Operating Income (+$)
Gross Profit1,266,887
Operating Expense-1,013,058
Operating Income253,829253,829
 
Operating Expense (+$)
Research Development195,972
Selling General Administrative112,499
Selling And Marketing Expenses244,800
Operating Expense1,013,058553,271
 
Net Interest Income (+$)
Interest Income0
Interest Expense-69,244
Other Finance Cost-69,244
Net Interest Income0
 
Pretax Income (+$)
Operating Income253,829
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)236,424271,234
EBIT - interestExpense = 184,585
236,425
241,708
Interest Expense69,244
Earnings Before Interest and Taxes (EBIT)253,829305,668
Earnings Before Interest and Taxes (EBITDA)413,347
 
After tax Income (+$)
Income Before Tax236,424
Tax Provision-0
Net Income From Continuing Ops0236,424
Net Income172,464
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,420,415
Total Other Income/Expenses Net-17,4050
 

Technical Analysis of Zim Laboratories Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zim Laboratories Limited. The general trend of Zim Laboratories Limited is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zim Laboratories Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zim Laboratories Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 119.30 < 127.40 < 128.75.

The bearish price targets are: 99.74 > 99.73 > 92.40.

Tweet this
Zim Laboratories Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zim Laboratories Limited. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zim Laboratories Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zim Laboratories Limited. The current macd is -1.0949052.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zim Laboratories Limited price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zim Laboratories Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zim Laboratories Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zim Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) ChartZim Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zim Laboratories Limited. The current adx is 22.67.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zim Laboratories Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Zim Laboratories Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zim Laboratories Limited. The current sar is 118.17.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zim Laboratories Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zim Laboratories Limited. The current rsi is 43.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Zim Laboratories Limited Daily Relative Strength Index (RSI) ChartZim Laboratories Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zim Laboratories Limited. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zim Laboratories Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Zim Laboratories Limited Daily Stochastic Oscillator ChartZim Laboratories Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zim Laboratories Limited. The current cci is -94.71707652.

Zim Laboratories Limited Daily Commodity Channel Index (CCI) ChartZim Laboratories Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zim Laboratories Limited. The current cmo is -17.48065931.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zim Laboratories Limited Daily Chande Momentum Oscillator (CMO) ChartZim Laboratories Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zim Laboratories Limited. The current willr is -84.14507772.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Zim Laboratories Limited Daily Williams %R ChartZim Laboratories Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zim Laboratories Limited.

Zim Laboratories Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zim Laboratories Limited. The current atr is 4.77564741.

Zim Laboratories Limited Daily Average True Range (ATR) ChartZim Laboratories Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zim Laboratories Limited. The current obv is 17,262,664.

Zim Laboratories Limited Daily On-Balance Volume (OBV) ChartZim Laboratories Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zim Laboratories Limited. The current mfi is 64.94.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zim Laboratories Limited Daily Money Flow Index (MFI) ChartZim Laboratories Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zim Laboratories Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Zim Laboratories Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zim Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.347
Ma 20Greater thanMa 50106.472
Ma 50Greater thanMa 100108.761
Ma 100Greater thanMa 200110.495
OpenGreater thanClose104.550
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Zim Laboratories Limited with someone you think should read this too:
  • Are you bullish or bearish on Zim Laboratories Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zim Laboratories Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zim Laboratories Limited

I send you an email if I find something interesting about Zim Laboratories Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Zim Laboratories Limited.

Receive notifications about Zim Laboratories Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.